Stay updated on TAA-Specific CTLs in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the TAA-Specific CTLs in Pancreatic Cancer Clinical Trial page.

Latest updates to the TAA-Specific CTLs in Pancreatic Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded detailed outcome definitions for progression-free survival and overall survival, and updated key study dates (completion date 2025-07-31; last update posted estimated 2025-10-02/2025-10-29). Removed the prior generic 'To evaluate...' statements related to these outcomes.SummaryDifference1.0%

- Check15 days agoNo Change Detected
- Check36 days agoChange DetectedNew operating-status notice and v3.2.0 release; prior v3.1.0 revision removed.SummaryDifference3%

- Check44 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.1%

- Check58 days agoChange DetectedUpdated to Revision: v3.0.2 (replacing v3.0.1); removed the Back to Top link.SummaryDifference0.2%

- Check65 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%

- Check72 days agoChange DetectedThe web page has undergone significant changes, including the removal of specific location details and resources related to pancreatic cancer, while also adding a facility name and a new version revision number.SummaryDifference1%

Stay in the know with updates to TAA-Specific CTLs in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAA-Specific CTLs in Pancreatic Cancer Clinical Trial page.